Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01248871
Other study ID # VAPOR 001
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 2010
Est. completion date October 2012

Study information

Verified date April 2024
Source University Medical Center Groningen
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To compare the renal protective properties of two currently used anaesthetic techniques - a sevoflurane-remifentanil/sufentanil combination with a propofol-remifentanil/sufentanil combination for anaesthesia in patients undergoing living donor kidney donation/transplantation.


Recruitment information / eligibility

Status Completed
Enrollment 120
Est. completion date October 2012
Est. primary completion date October 2012
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - All patients: Age > 18 years Exclusion Criteria: - patient refusal - BMI< 17, >35 - neurological disorder - recent use of psycho-active medication, including alcohol. - Donor-recipient couples from the ABO-incompatible program - Altruistic donor

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
procedure:sevoflurane-remifentanil/sufentanil
Active Comparator
volatile agent only during reperfusion
Active Comparator
propofol-remifentanil/sufentanil
Active Comparator

Locations

Country Name City State
Netherlands University Medical Center Groningen Groningen

Sponsors (1)

Lead Sponsor Collaborator
University Medical Center Groningen

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary To compare the renal protective properties of two currently used anaesthetic techniques participants will be followed for the duration of hospital stay